Check out the latest updates from Cinclus Pharma
Highlights from the 2024 Annual Report: Interview with Dr. Prateek Sharma. Dr. Prateek Sharma, Medical Advisor and expert in gastrointestinal diseases and cancer, shares his insights on its safety and potential usage areas.
Read more
Highlights from the 2024 Annual Report: Interview with Nina Rawal. Trill Impact Ventures views Cinclus Pharma as a strong Life Science candidate with the potential to address unmet medical needs in GERD and H. pylori. Nina Rawal, Co-Head of Ventures and a board member at Cinclus Pharma, contributes her biomedical expertise and financing experience.
Read more
Highlights from the 2024 Annual Report: Interview with Kajsa Larsson. The study will involve around 500 patients from eight countries in Europe and North America, with up to 100 hospitals and clinics.
Read more